Key Takeaways
- Researchers at the University of Southampton identified a pump in E. coli that expels antibiotics, aiding in its survival during treatment.
- The MdtF pump is activated by stomach acid and supports biofilms, making infections harder to treat.
- Findings could lead to new strategies for combating antibiotic-resistant bacteria.
New Discovery in E. coli Survival Mechanisms
Recent research has revealed that E. coli possesses a sophisticated mechanism to withstand antibiotic treatment, presenting significant challenges in medical settings. A team from the University of Southampton uncovered a super-pump within E. coli and its related Shigella species known as MdtF. This pump, triggered by stomach acid, actively ejects antibiotics before they can exert their effects.
Lead author Ryan Lawrence, a molecular scientist at the university, indicated that understanding how the MdtF protein protects E. coli inside the human body is crucial for addressing rising antibiotic resistance. He explained, “Our research shows that this pump activates in response to the acid in our stomach, cleaning house and sweeping away toxins, even antibiotics.” This mechanism also supports the formation of biofilms, contributing to persistent and severe infections.
While most E. coli strains are harmless and coexist in human intestines, antibiotic-resistant variants are categorized by the World Health Organization as critical global threats. Resistance complicates treatment efforts, often leading to increased mortality rates and extended hospital stays. The Southampton team utilized cryo-electron microscopy to analyze the three-dimensional structure of the MdtF pump, revealing its ability to change shape and effectively expel harmful molecules, thereby fortifying itself against antibiotics.
Co-lead researcher Dr. Eamonn Reading emphasized that the pump is particularly effective in the challenging conditions of the gut, which are both low in oxygen and acidic. “This makes it more resistant to the drugs we use against E. coli,” he noted.
The team’s findings open avenues for developing innovative treatments aimed at combating drug-resistant superbugs. Dr. Reading remarked, “Now we know the blueprint for this E. coli super-pump, we can work on a better way to jam this class of antibiotic cleaners. We could create drugs that can break the pump, making the bugs increasingly defenseless against normal antibiotics.”
This study, published in Nature Communications, offers a significant insight into the mechanisms of antibiotic resistance and lays the groundwork for potential new therapeutic strategies. The research team hopes their results lead to methods that can effectively impair the MdtF pump, thus enhancing the efficacy of existing antibiotics against resistant strains.
For further details, the study can be accessed at doi.org/10.1038/s41467-025-65565-7.
The content above is a summary. For more details, see the source article.